CRL Charles River
- 232.355
- +3.325+1.45%
Charles River News
The "highest Quality" Stocks Within Each Sector - GS
Iterum Therapeutics Resubmits New Drug Application to U.S. FDA for Oral Sulopenem
With Rate Cuts Pushed Out, Goldman Looks at Quality Stocks
Investors are looking to quality stocks amid the prospect of delayed Fed rate cuts.
Charles River Laboratories International, Inc.'s (NYSE:CRL) Price Is Out Of Tune With Earnings
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 16x, you may consider Charles River Laboratories International, Inc. (NYSE:CRL) as a stock to potentially avoid with its 24.8x P/E ratio.
FibroBiologics, Charles River Laboratories Sign Letter Of Intent Allowing For Transfer, Testing And Validation Of Technology
This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of FibroBiologics' master cell bank, working cell bank, and fibroblast-based sp
Express News | Fibrobiologics Plans to Collaborate With Charles River to Manufacture Fibroblast-Based Spheroids
Express News | Charles River Shares Are Trading Higher in Possible Sympathy With Danaher, Which Reported Better-than-expected Q1 Financial Results
Charles River Associates (CRA) to Host First-Quarter Fiscal 2024 Financial Results Conference Call on May 2
Conference Call to be Webcast Live at 10:00 a.m. ET Charles River Associates (NASDAQ:CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that the company
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
Company marks significant progress towards climate goals, reaching the milestone considerably ahead of scheduleWILMINGTON, Mass.--(BUSINESS WIRE)--$CRL #LIFEatCRL--Charles River Laboratories Internati
Here's Why You Should Retain Charles River (CRL) Stock Now
Express News | Charles River Laboratories International - Initiative Focuses on Innovation, Partnerships, Advocacy as Part of $500 Mln Investment in Driving Change
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it is launching its Alternative Methods Advancement Project (AMAP), an initiative dedicated to developing alternatives to reduce animal testing.
ICLR or CRL: Which Is the Better Value Stock Right Now?
Zacks Investment Research Adjusts Charles River Laboratories International's Price Target to $259 From $278
Zacks Investment Research Adjusts Charles River Laboratories International's Price Target to $259 From $278.
Press Release: Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call WILMINGTON, Mass.--(BUSINESS WIRE)--April 12, 2024-- Charles River Laboratories International, Inc. (NYSE
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Could Be 24% Below Their Intrinsic Value Estimate
Key Insights Charles River Laboratories International's estimated fair value is US$328 based on 2 Stage Free Cash Flow to Equity Charles River Laboratories International's US$247 share price signals
T. Rowe Price Expands Use of Cloud-Based Charles River IMS
Charles River Development, a State Street Company, announced today that T. Rowe Price will transition to Charles River's cloud-based technology platform. T. Rowe Price will utilize the Charles River Investment
Charles River (CRL) Forges Collaboration With Ship of Theseus
Charles River and Axovia Partner on Gene Therapy Production
Charles River To Collaborate With Axovia Therapeutics - Quick Facts
Analysis
Price Target
No Data
